Virbac SA (VRBCF PINK) stock market data APIs
$384.2043
0(0%)
as of March 24, 2026
Try our APIs with
free plan!
Virbac SA Financial Data Overview
Price chart is built with
Anychart
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Prev. Close
384.2043
Open
384.2043
High
384.2043
Low
384.2043
52 wk Range
320.9718-384.75
Market Cap
3 223 M
P/E Ratio
18.4532
Shares Outstanding
8 378 K
Revenue
1 465 M
Dividends (Yield)
0.0042
Beta
0.852
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Virbac SA data using free add-ons & libraries
Get Virbac SA Fundamental Data
Virbac SA Fundamental data includes:
- Net Revenue: 1 465 M
- EBITDA: 290 M
- Earnings Per Share: 20
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-17
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Virbac SA News
New
Assessing Virbac (ENXTPA:VIRP) Valuation As Investors Revisit The Stock’s Recent Performance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Why Virbac stock is on investors’ radar Virbac (ENXTPA:VIRP) has drawn fresh attention a...
Virbac: 2025 annual results
Virbac A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9% Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categorie...
Virbac : Declaration of the number of shares and voting rights 02/2026
Virbac DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulation...
Virbac : Declaration of the number of shares and voting rights 01/2026
Virbac DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulation...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
